Related Videos

  1. Dividend Appeal Lacking in Abbott Split-Up

    Fri, 9 Nov 2012

    The newly public AbbVie's dividend will be too concentrated to a single drug, while the payout from the remaining Abbott entity won't be as generous as in years past, according to Morningstar's Josh Peters.

  2. Declining Correlations Bring Stock-Picking to the Fore

    Fri, 1 Feb 2013

    Morningstar's Heather Brilliant explains why investors should care about movement in market and sector correlations.

  3. The Friday Five: Phoning It In

    Thu, 5 Sep 2013

    This week: tales from telecom, including Verizon's big buy, Microsoft's mobile mission, BlackBerry on the auction block, and more.

  4. Bargains Lacking for Dividend Funds

    Thu, 14 Feb 2013

    Recent Morningstar research shows that while some buys exist across the equity fund universe, many areas, such as dividend-paying stocks, are close to fully valued.

Content Partners